Re-Flow
Private Equity Round in 2025
Re-flow is a Devon-based company specializing in field management software tailored for the construction, highways, traffic management, civil engineering, rail, and landscaping sectors. The software offers a robust suite of features that facilitates job setup and task assignment, allowing field workers to access essential information through a mobile app. Users can view job specifications, complete tasks, and submit various forms related to health and safety, HR, and quality control, all while attaching relevant project documents and photos. The platform supports the creation of customizable forms to meet regulatory standards, ensuring compliance and enabling real-time data communication between the field and the management dashboard. Additionally, Re-flow's software automates workflows based on submitted data, enhancing job progress tracking and equipment management. With a proven track record of over 180 successful implementations, Re-flow is trusted by major industry players, helping them eliminate inefficiencies and elevate their field management processes.
Emas Pharma
Acquisition in 2024
Emas Pharma Limited is a contract research organization that specializes in providing a wide range of clinical research and development services to pharmaceutical and biotech companies worldwide. Established in 1996 and based in Hitchin, United Kingdom, with additional offices in the United States and Australia, the company offers comprehensive solutions that include the design and implementation of clinical trials, medical affairs, pharmacovigilance, and regulatory activities. Its clinical operations encompass early-phase trials, late-phase clinical studies, and medical writing services, while drug safety services involve case processing and post-marketing pharmacovigilance. Emas Pharma also supports clients with strategic consultancy in clinical development and product planning, alongside medical affairs services such as pre-launch readiness and marketing material certification. By focusing on the entire product lifecycle, Emas Pharma aims to enhance the development and commercialization of medicines, ensuring compliance with regulatory requirements and providing ongoing support for post-marketing commitments.
GXP Engaged Auditing Services
Acquisition in 2023
GXP Engaged Auditing Services is an accounting and auditing firm that provides QM auditing and consultancy services.
MAP Patient Access
Acquisition in 2023
MAP Patient Access is a pharmaceutical manufacturing firm that specializes in market access consulting services for the pharmaceutical and biotech sectors. The company offers a range of services, including early engagement, pricing strategy, health economics, outcomes research, and evidence communication. By providing these services, MAP Patient Access assists its clients in navigating the complex healthcare reimbursement processes globally, ensuring they can effectively position their products in the market.
DC Byte
Acquisition in 2022
DC Byte is a developer of a comprehensive data and analytics platform tailored for the data center sector. The platform offers a complete view of the market, encompassing both colocation and self-build enterprise assets. It integrates user-generated data from data center operators with proprietary researched content, ensuring that the information remains continuously updated and validated in real-time. This unique combination of data and advanced analytics equips clients with insights ranging from broad global perspectives to detailed granular information, facilitating informed decision-making within the data center industry.
Optibrium
Private Equity Round in 2022
Optibrium is a software company that specializes in providing innovative solutions for small molecule design, optimization, and data analysis, aimed at enhancing the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an additional office in Boston, US, the company’s flagship product, StarDrop, is a comprehensive and user-friendly software suite that facilitates the integration of data, predictive modeling, and decision-making in research. This tool enables users to streamline their workflow from data analysis to compound synthesis, thereby increasing the speed and efficiency of drug discovery. Optibrium collaborates with a diverse range of clients, including leading pharmaceutical companies, biotech firms, and academic institutions, to continuously develop new technologies and improve productivity in drug development.
Rephine
Acquisition in 2021
Rephine is a global audit and consultancy firm that serves the pharmaceutical, medical device, and biotechnology industries. The company specializes in conducting good manufacturing practice (GMP) and good clinical practice (GCP) audits, as well as offering regulatory consulting services. Rephine is dedicated to helping clients navigate the complexities of compliance with applicable good practices through innovative solutions that address the challenges posed by stringent auditing requirements. In addition to its audit and consultancy services, Rephine provides GMP training to equip clients with the necessary knowledge and skills to meet industry standards.
Optibrium
Private Equity Round in 2021
Optibrium is a software company that specializes in providing innovative solutions for small molecule design, optimization, and data analysis, aimed at enhancing the drug discovery process. Founded in 2009 and headquartered in Cambridge, UK, with an additional office in Boston, US, the company’s flagship product, StarDrop, is a comprehensive and user-friendly software suite that facilitates the integration of data, predictive modeling, and decision-making in research. This tool enables users to streamline their workflow from data analysis to compound synthesis, thereby increasing the speed and efficiency of drug discovery. Optibrium collaborates with a diverse range of clients, including leading pharmaceutical companies, biotech firms, and academic institutions, to continuously develop new technologies and improve productivity in drug development.
You Garden
Acquisition in 2019
You Garden Limited is an online retailer based in Kings Lynn, United Kingdom, specializing in a wide range of gardening products. Founded in 2011, the company offers an extensive selection of flowers, trees, shrubs, fruits, and vegetables, as well as gardening machinery and gifts tailored for gardening enthusiasts. With a focus on providing quality products, You Garden aims to cater to the diverse needs of gardeners, enhancing their gardening experience.
VIXIO Regulatory Intelligence
Private Equity Round in 2019
VIXIO Regulatory Intelligence is a provider of independent and authoritative insights into regulatory developments, primarily serving the payments and gambling sectors. The company offers a platform that delivers comprehensive news, legal analysis, and market commentary to a diverse clientele, including operators, regulators, technology providers, and law firms. By equipping regulatory and legal teams with actionable intelligence, VIXIO enables its clients to navigate complex regulatory landscapes effectively, manage risks confidently, and identify new market opportunities. With a focus on timely and in-depth information, VIXIO stands as a trusted resource for businesses seeking to make informed decisions in a rapidly evolving regulatory environment.
ComplianceOnline
Acquisition in 2019
ComplianceOnline is the provider of legal, regulatory and business intelligence for the gambling and payments industries. We specialise in providing high level and independent insights, analysis, data and research through our primary services GamblingCompliance and PaymentsCompliance. Through our advanced web-based technology platform we provide industry professionals with the critical information they need to understand what regulatory change today means for the business opportunities of tomorrow. We pride ourselves on providing the most comprehensive, accurate and up-to-date information services and eLearning courses. Based in London, Washington, D.C., California and Taipei, ComplianceOnlines’s team of in-house analysts and journalists boast an unrivaled network of contacts among policymakers, lobbyists and legal experts, as well as a wealth of experience to analyse what regulatory change and market developments today, means for business opportunities tomorrow. Our clients include global law firms and legal professionals, regulators, advisory communities, online and terrestrial operators, lotteries, financial institutions, fintech and start-up companies, and payment technology and service providers. Learn more at: https://gamblingcompliance.com/ https://paymentscompliance.com/
CETA Insurance
Acquisition in 2017
CETA Insurance is a leading provider of personal and commercial insurance distribution services in the United Kingdom. The company specializes in offering a diverse range of insurance products sourced from some of the UK's top insurance providers. CETA employs a tech-enabled online broking platform that facilitates efficient distribution and enhances the customer experience. Additionally, the company supports insurers with tools for quoting, selling, and processing their business, along with an introducer scheme that allows partners to earn income without engaging directly in policy sales. CETA's strong digital marketing capabilities and deep data insights have positioned it as an innovator in the insurance market, fostering recurring customer relationships and establishing a solid presence in its core channels.
Avania
Private Equity Round in 2016
Avania is a full-service contract research organization dedicated to managing clinical studies for a range of products, including medical devices, in vitro diagnostics, biologics, and combination products. The company specializes in providing tailored contract research services specifically for the medical device sector, guiding clients through all phases of product development, from feasibility studies to post-approval trials. Avania's expertise encompasses advanced technologies and novel products, enabling it to offer customized and scalable solutions that enhance operational efficiencies and facilitate the progression of medical technology on an international scale.
Frontier Medical Group
Private Equity Round in 2013
Frontier Medical Group is a prominent supplier of consumable products and services to healthcare providers in the UK, Europe, and internationally. The company specializes in the manufacturing of pressure area care and infection control products, which play a critical role in maintaining patient safety and hygiene. Its product offerings include sharps disposal containers, clinical waste disposal containers, and harm reduction products, all designed to address the specific needs of healthcare environments. Through its commitment to quality and innovation, Frontier Medical Group supports healthcare professionals in delivering effective and safe patient care.
Garrets International
Acquisition in 2012
Garrets International specializes in outsourced marine catering management for the global commercial shipping industry. It serves approximately 1000 vessels owned by prominent players in world shipping, offering a comprehensive suite of services including hygiene and food safety management, procurement, crew welfare initiatives, and training programs aimed at reducing administration costs, enhancing nutrition, minimizing food waste, and streamlining processes.
AgriBriefing
Acquisition in 2012
AgriBriefing is a business media company based in London, UK, that specializes in providing pricing benchmarks, data analytics, and market intelligence for the global agriculture and food sectors. Founded in 2010 by media executives Neil Thackray and Rory Brown, the company initially launched TheMediaBriefing to serve the media industry before expanding its focus to agriculture in 2012 through the acquisition of Farmers Guardian and Pulse. AgriBriefing has further enhanced its portfolio with acquisitions such as LAMMA, a leading agricultural equipment exhibition, and Agrimoney, a recognized intelligence portal for international agribusiness. The company offers critical market data and proprietary insights to approximately 250,000 farming decision-makers, enabling them to make informed commercial and strategic decisions.
Industry Dynamics
Private Equity Round in 2011
Industry Dynamics is a business-to-business events organizer that specializes in hosting a diverse array of medium and large scale events. Operating primarily in Europe and North America, the company focuses on key sectors such as energy, pharmaceuticals, food and beverage, supply chain, and business services. In addition to event organization, Industry Dynamics provides training and online lead generation services, enhancing its offerings to clients and participants in various industries.
Chiltern International
Private Equity Round in 2010
Chiltern International Limited is a prominent contract research organization that specializes in clinical development and scientific services for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of services, including early and late-phase clinical development, biostatistics, and medical and regulatory affairs. Chiltern serves various specialty areas within the biopharmaceutical and medical device industries, utilizing diverse engagement models to meet the specific needs of its clients. In addition to its clinical services, Chiltern also provides resourcing solutions to support the operational requirements of its partners. Through its expertise and collaborative technologies, the company plays a crucial role in advancing clinical research and development.
Chiltern International
Acquisition in 2010
Chiltern International Limited is a prominent contract research organization that specializes in clinical development and scientific services for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of services, including early and late-phase clinical development, biostatistics, and medical and regulatory affairs. Chiltern serves various specialty areas within the biopharmaceutical and medical device industries, utilizing diverse engagement models to meet the specific needs of its clients. In addition to its clinical services, Chiltern also provides resourcing solutions to support the operational requirements of its partners. Through its expertise and collaborative technologies, the company plays a crucial role in advancing clinical research and development.
Travel Entertainment Group
Private Equity Round in 2008
Travel Entertainment Group, Ltd. provides entertainment services to the airline industry.
Ironshore Insurance
Private Equity Round in 2007
Ironshore Insurance, established in 2006 and headquartered in Hamilton, Bermuda, specializes in providing commercial property and casualty insurance products globally, including in the United States and Bermuda. The company offers a diverse range of coverages, such as professional and management liability, environmental and specialty casualty insurance, aviation, political risk, and surety products. Additionally, Ironshore caters to specific sectors including real estate, hospitality, and energy, while also underwriting catastrophic excess casualty and healthcare insurance. Certain specialty coverages are underwritten at Lloyd’s through Ironshore’s Pembroke Syndicate 4000. The company is recognized for its strong financial standing, holding an A (Excellent) rating from A.M. Best. Ironshore operates primarily in the wholesale market, focusing on complex and unique risks, and is committed to delivering customized insurance solutions and improved claims outcomes. As of May 2017, Ironshore operates as a subsidiary of Liberty Mutual Group.
Xanthus Pharmaceuticals
Series B in 2006
Xanthus Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the discovery, development, acquisition, and commercialization of small-molecule therapeutics. The company primarily focuses on creating innovative treatments for cancer and autoimmune disorders, aiming to address unmet medical needs in these areas. Through its research and development efforts, Xanthus Pharmaceuticals strives to advance therapeutic options that can improve patient outcomes and enhance the quality of care in oncology and immunology.